NewEdge Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.96K | Buy |
4,625
+500
| +12% | +$860 | ﹤0.01% | 3275 |
|
|
2025
Q1 | $13.7K | Buy |
4,125
+490
| +13% | +$1.63K | ﹤0.01% | 2987 |
|
|
2024
Q4 | $26.9K | Hold |
3,635
| – | – | ﹤0.01% | 2720 |
|
|
2024
Q3 | $34.1K | Hold |
3,635
| – | – | ﹤0.01% | 2552 |
|
|
2024
Q2 | $29.2K | Buy |
3,635
+500
| +16% | +$4.01K | ﹤0.01% | 2513 |
|
|
2024
Q1 | $46.5K | Buy |
3,135
+1,335
| +74% | +$19.8K | ﹤0.01% | 2339 |
|
|
2023
Q4 | $14.6K | Hold |
1,800
| – | – | ﹤0.01% | 2702 |
|
|
2023
Q3 | $8.19K | Buy |
1,800
+1,100
| +157% | +$5.01K | ﹤0.01% | 2645 |
|
|
2023
Q2 | $4.93K | Buy |
+700
| New | +$4.93K | ﹤0.01% | 2823 |
|